SHPH (Shuttle Pharmaceuticals Holdings, Inc.) Multiplikator EV/Sales

shuttlepharma.com (SHPH) - logo korporat

Shuttle Pharmaceuticals is developing radiosensitizers to combat brain tumors, despite the binary risks associated with its pipeline. A review of the company's current price-to-sales valuation on GURU.Markets reveals growth, with the metric standing at 0.00. This is supported by a staff of specialized oncologists and a strategy of large-scale expansion within the oncology drug segment to facilitate the imminent commercial launch of its products.

SHPH (Shuttle Pharmaceuticals Holdings, Inc.) riwayat Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

shuttlepharma.com - rincian analitis lan metrik utama (SHPH)

Pambiji fundamental:shuttlepharma.com SHPH
Barang unggulan Shuttle Pharmaceuticals

For Shuttle Pharmaceuticals (SHPH), which invests its reserves into R&D for cancer therapy sensitizers, this indicator determines the real value of commercial turnover by excluding distortions from the debt load. By analyzing the company's enterprise value-to-revenue trajectory, an investor can identify pricing integrity: abnormal stability of the line despite high development costs may signal an artificial support of quotes in the face of capital burn.